Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-16-000761

Options or other derivatives

  • Chief Financial Officer acquired 75,858 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Hippel James · Chief Financial Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2016-08-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +40,533 40,533 D
2016-08-18 Grant or award : show line 2 in the form Stock Option (Right to Buy) +30,400 30,400 D
2016-08-18 Grant or award : show line 3 in the form Restricted Stock Unit +4,925 4,925 D
Loading xslF345X03/edgar.xml…